New Arrivals/Restock

Drug Adherence in Hypertension and Cardiovascular Protection (Updates in Hypertension and Cardiovascular Protection) 1st ed. 2018 Edition, Kindle Edition

flash sale iconLimited Time Sale
Until the end
07
16
47

US$53.40 cheaper than the new price!!

Free shipping for purchases over $99 ( Details )
Free cash-on-delivery fees for purchases over $99
Please note that the sales price and tax displayed may differ between online and in-store. Also, the product may be out of stock in-store.
Used  US$35.60
quantity

Product details

Management number 219240578 Release Date 2026/05/03 List Price US$35.60 Model Number 219240578
Category

This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence. The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases. Read more

XRay Not Enabled
ISBN13 978-3319765938
Edition 1st ed. 2018
Language English
File size 13.8 MB
Page Flip Enabled
Publisher Springer
Word Wise Not Enabled
Print length 596 pages
Accessibility Learn more
Screen Reader Supported
Part of series Updates in Hypertension and Cardiovascular Protection
Publication date June 27, 2018
Enhanced typesetting Enabled

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Product Review

You must be logged in to post a review